Solsten Diagnostics International ApS offers strategic partners and prospective investors a wide range of opportunities
– First-mover opportunities in a fast-growing market
Expand and/or preserve existing market share for point-of-care testing (POCT) in a fast-growing market.
Solsten Diagnostics International ApS creates possibilities for first-mover advantages in the POCT market for infectious diseases with a highly reliable technology equivalent to PCR technology. The quick “one-step” user interface also opens up new market opportunities in both hospitals and primary care units.